BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 1, 2010
View Archived Issues
Greater blood pressure reduction seen with LCZ-696 than with valsartan in hypertension
Read More
Pfizer describes identification of selective 5-HT6 receptor antagonist WAY-262531
Read More
Preclinical safety of oseltamivir supports clinical development in infants
Read More
Studies describe pharmacokinetics, interactions with renin inhibitor ACT-178882/MK-1597
Read More
GLY-230 may ameliorate renal disease in patients with diabetes
Read More
Discovery of HCV protease inhibitor BMS-650032 described
Read More
Targacept presents novel nicotinic acetylcholine alpha4beta2 receptor ligands
Read More
UHN claims new triazolium and imidazolium salts for treatment of parasitic infections
Read More
Repligen discovers novel HDAC3 inhibitors
Read More
Emory University claims new noscapine analogues for cancer therapy
Read More
Addex and Ortho-McNeil-Janssen claim positive allosteric mGlu2 modulators
Read More
Patient enrollment initiated in phase II study of Reolysin for SCC lung cancer
Read More
Emory University and Zirus enter a collaboration and research agreement to create new antivirals
Read More
SciClone reports topline phase II data on SCV-07 for prevention of oral mucositis
Read More
FDA issues complete response letter on AstraZeneca and Abbott's Certriad NDA for mixed dyslipidemia
Read More
FDA approves Asclera for treatment of small varicose veins
Read More
Eisai submits anticancer agent eribulin for approval in Japan, U.S. and Europe
Read More
Banyu submits V-260 rotavirus vaccine for approval in Japan
Read More
BioDiem provides update on pandemic influenza vaccine program
Read More
NexMed files IND with FDA for phase II trial of PrevOnco in hepatocellular carcinoma
Read More
Action Pharma completes dosing in phase II AP-214 trial
Read More
FDA accepts voclosporin NDA for priority review
Read More
YM BioSciences expands ongoing phase I/II CYT-387 study in myelofibrosis
Read More
Titan begins phase III study of Probuphine in opioid addiction
Read More
PolyMedix completes phase Ib trial of novel antibiotic PMX-30063
Read More
Critical Outcome Technologies reports preclinical data on oral COTI-2 in TNBC model
Read More